Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing ...

CI Financial (TSX:CIX:CA) (OTCPK:CIXXF) received an interim order from the Ontario Superior Court of Justice that authorizes, ...

Tenvie Therapeutics is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug ...

Backed by ARCH Venture Partners, F-Prime Capital and Mubadala Capital, the new company will develop a pipeline of ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

CI Financial receives an interim court order concerning the transaction under which CI shares will be acquired by an ...

Advancing a deep pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseasesLed by expert R&D ...

CI Financial Corp. has received an interim court order for its proposed plan of arrangement with Mubadala Capital, allowing the acquisition of its shares for $32.00 per share, exc ...

State-owned investors, notably sovereign wealth funds (SWFs) and public pension funds (PPFs), are significantly increasing ...

Howden is being advised on the raise by Morgan Stanley.

ABU Dhabi’s Mubadala Investment was the world’s most active sovereign wealth fund (SWF) last year as it ramped up deal-making ...